Skip to main content
. 2022 Oct 13;19(20):13173. doi: 10.3390/ijerph192013173

Table 2.

Characteristics of the study group (n = 394).

Gender, n (%)
female 256 (65.0)
male 138 (35.0)
Age (years)
M ± SD 35.34 ± 11.36
Min-Max 18.0–77.0
Education, n (%)
Primary/vocational 23 (5.9)
Secondary 145 (36.9)
Tertiary 225 (57.3)
Place of residence, n (%)
Countryside 88 (22.3)
Small town 125 (31.7)
Big city 181 (45.9)
Disease duration (years)
M ± SD 14.88 ± 10.71
Min-Max 1.0–54.0
BMI categories, n (%)
<18.5 kg/m2 5 (1.3)
18.6–24.9 kg/m2 208 (52.8)
25.0–29.9 kg/m2 126 (32.0)
30.0–34.9 kg/m2 40 (10.2)
>35.0 kg/m2 15 (3.8)
Type of insulin therapy, n (%)
Insulin pen 221 (56.1)
Insulin pump 173 (43.9)
Insulin units per day
M ± SD 43.04 ± 19.32
Min–Max 10.0–140.0
Insulin units per kilogram of body weight
M ± SD 0.58 ± 0.22
Min–Max 0.1–1.6
Hypoglycemia episodes, n (%)
every day 23 (5.8)
5–6 times a week 35 (8.9)
4–3 times a week 78 (19.8)
1–2 times a week 123 (31.2)
only once 70 (17.8)
never 65 (16.5)
Hyperglycemia episodes, n (%)
every day 74 (18.8)
5–6 times a week 75 (19.0)
4–3 times a week 87 (22.1)
1–2 times a week 72 (18.3)
only once 47 (11.9)
never 39 (9.9)
Knowledge of insulin/CEs ratio, n (%) 320 (81.2)
Knowledge of CEs consumed daily, n (%) 261 (66.2)
Knowing the calorie value of one’s diet, n (%) 170 (43.1)

M—mean, SD—standard deviation, CEs—carbohydrate exchanges.